Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Retinal Detachment: later-stage trial registry

2 of 4 indexed Retinal Detachment trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Retinal Detachment: 4 US clinical trials tracked, 2 recruiting.

Retinal Detachment is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Loma Linda University, running 1 of these trials.

Enrollment posture brief

Registry condition retinal-detachment

OPEN 2 | RECR 50% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Retinal Detachment (this)50%
Open-enrollment share among volume-matched conditions near Retinal Detachment

Retinal Detachment lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Retinal Detachment on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Retinal Detachment is recruiting above its size-band peers.

    2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Retinal Detachment records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Ophthalmology Assessment Other
1 trials
Triamcinolone Acetonide 40mg/mL Drug
1 trials
Microscope integrated optical coherence tomography Device
1 trials
Ultrasound Device
1 trials

US sites by state

Facility locations filed on Retinal Detachment trials. A trial with sites in several states counts in each.

Virginia 1 trials
Ohio 1 trials
North Carolina 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Retinal Detachment page

4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Retinal Detachment condition card totals 4 registered trials; most-linked intervention Ophthalmology Assessment; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.